Wave Life Sciences Ltd.
NASDAQWave Life Sciences exits its May earnings week battered — down 10% in a single session and nearly 10% on the week — with analysts racing to reprice a stock that has lost more than half its value this year. The post-earnings damage is the story this week. The company reported on May 18 and dropped 9.3% the following day. That follows a softer reaction to the May 8 event, where the…
WVE short interest surges 26.7% in one week to 10.7% of float as biotech stock slides.
Snapshot as of 22 Jun 2026
Wave Life Sciences exits its May earnings week battered — down 10% in a single session and nearly 10% on the week — with analysts racing to reprice a stock that has lost more than half its value this year. The…
Wave Life Sciences presents a rare split-signal setup. Short sellers are building positions hard. Options traders are piling into calls. Analysts keep Buy ratings but are slashing targets. All three moved sharply in…
Wave Life Sciences heads into its May 8 earnings with one dominant story: a $55 million insider buying cluster that now looks increasingly misaligned with where the stock and analyst targets sit. The most compelling…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for WVE — free to start on ORTEX.
Sign up for free →Open WVE on ORTEX